Our fundraise for Celsium – which has created a world-first, medical-grade device for the healthcare sector and the home, which continuously measures core body temperature, accurately and non-invasively – was featured in the print edition of the Sunday Express over the weekend.

As well as covering the fundraise, the piece included some details on how the Celsium device works, explaining that an armpit-mounted temperature sensor connects via Bluetooth to a smart monitoring platform.

Celsium is seeking to raise just over £752k of EIS-qualifying equity through our network in order to implement its growth strategy, which includes increasing unit production to enable fulfilment of the pipeline, plus funding the next stage of development work on new products and clinical studies.

In addition to the Sunday Express coverage, the fundraise news has appeared across various trade press sites and publications, including –

Temperature Wearable Maker to Raise Capital for Expansion (MedTech News)

Wearable Temperature Monitoring Firm Raises Capital for its Expansion Amid Covid-19 Demand (MobiHealthNews)

Shaz Hussain, Investment Director at Growthdeck, says:

“Celsium is uniquely placed to meet an urgent need for accurate, non-invasive, medical-grade temperature monitoring that is suddenly a top priority for both consumers and healthcare organisations.”

“Coronavirus has created disruption across the economy, but disruption means opportunity for businesses with the right product. Celsium is one of those businesses.”

Andrew Mahoney, Founder and CEO at Celsium, says:

“We’re hugely excited to be working with Growthdeck to raise this investment. Celsium has the potential to change the way the world measures temperature and this investment will allow us to scale at pace, unlocking new markets and uses, ranging from at home through to other areas such as healthcare, research and elite sports.”